Skip to main content

Table 5 Predictors of mortality (medications) after hip fracture in AD and non-AD cohorts (persons with previous fractures excluded)

From: Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer’s disease – exposure-matched cohort study

Risk factor

Category

AD cohort

Non-AD cohort

Mortality/ 100 PY

Unadjusted HR

(95% CI)

Adjusted HRa

(95% CI)

Mortality/ 100 PY

Unadjusted HR

(95% CI)

Adjusted HRa

(95% CI)

Any CVD medication

Yes

31.6

1.12 (1.03–1.22)

1.18 (1.08–1.29)

28.1

1.25 (1.02–1.54)

1.28 (1.04–1.58)

No

24.7

1.00 (reference)

1.00 (reference)

17.4

1.00 (reference)

1.00 (reference)

Yes

30.0

1.17 (1.05–1.31)

1.17 (1.04–1.31)

24.0

1.36 (1.06–1.74)

1.37 (1.07–1.76)

Drugs for obstructive airway diseases

No

28.3

1.00 (reference)

1.00 (reference)

23.1

1.00 (reference)

1.00 (reference)

Yes

35.3

1.25 (1.12–1.39)

1.17 (1.05–1.30)

24.3

1.04 (0.88–1.23)

1.11 (0.94–1.32)

Hormone therapy

No

29.8

1.00 (reference)

1.00 (reference)

23.7

1.00 (reference)

1.00 (reference)

 

Yes

18.6

0.63 (0.49–0.80)

0.81 (0.64–1.04)

11.7

0.50 (0.29–0.85)

0.78 (0.46–1.32)

Bisphosphonates

No

29.5

1.00 (reference)

1.00 (reference)

23.7

1.00 (reference)

1.00 (reference)

 

Yes

28.1

0.95 (0.85–1.07)

1.07 (0.95–1.20)

21.0

0.88 (0.72–1.06)

1.06 (0.87–1.29)

Proton pump inhibitors

No

26.8

1.00 (reference)

1.00 (reference)

21.0

1.00 (reference)

1.00 (reference)

Yes

33.4

1.24 (1.15–1.35)

1.25 (1.15–1.36)

26.8

1.27 (1.12–1.45)

1.31 (1.15–1.49)

Anti–Parkinson drugs

No

29.28

1.00 (reference)

1.00 (reference)

23.12

1.00 (reference)

1.00 (reference)

Yes

29.10

0.99 (0.84–1.18)

1.02 (0.86–1.21)

27.15

1.18 (0.91–1.54)

1.20 (0.92–1.56)

Antiepileptics drugs

No

29.0

1.00 (reference)

1.00 (reference)

23.6

1.00 (reference)

1.00 (reference)

 

Yes

31.9

1.10 (0.96–1.25)

1.12 (0.99–1.28)

21.2

0.90 (0.72–1.11)

0.98 (0.79–1.21)

Antipsychotics

No

28.2

1.00 (reference)

1.00 (reference)

22.3

1.00 (reference)

1.00 (reference)

 

Yes

31.1

1.10 (1.01–1.20)

1.16 (1.06–1.26)

30.9

1.41 (1.18–1.68)

1.41 (1.18–1.68)

Antidepressants

No

30.7

1.00 (reference)

1.00 (reference)

22.1

1.00 (reference)

1.00 (reference)

 

Yes

27.5

0.89 (0.82–0.97)

0.97 (0.89–1.05)

26.9

1.22 (1.05–1.40)

1.29 (1.11–1.48)

BZDRS

No

28.4

1.00 (reference)

1.00 (reference)

21.3

1.00 (reference)

1.00 (reference)

 

Yes

30.2

1.06 (0.98–1.15)

1.06 (0.98–1.15)

25.7

1.21 (1.06–1.38)

1.18 (1.04–1.35)

Opioids

No

25.5

1.00 (reference)

1.00 (reference)

18.7

1.00 (reference)

1.00 (reference)

 

Yes

32.9

1.30 (1.20–1.41)

1.29 (1.19–1.40)

28.5

1.50 (1.31–1.72)

1.56 (1.36–1.79)

  1. aAdjusted for occupational social class